Back to search results

Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Acute Myeloid Leukemia · Acute Undifferentiated Leukemia · Mixed Phenotype Acute Leukemia · Recurrent Acute Myeloid Leukemia · Recurrent Acute Undifferentiated Leukemia · Recurrent Chronic Myelomonocytic Leukemia · Recurrent Mixed Phenotype Acute Leukemia · Recurrent Myelodysplastic Syndrome · Refractory Acute Myeloid Leukemia · Refractory Acute Undifferentiated Leukemia · Refractory Chronic Myelomonocytic Leukemia · Refractory Mixed Phenotype Acute Leukemia · Refractory Myelodysplastic Syndrome · Secondary Acute Myeloid Leukemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

    Contact: Study coordinator (Naveed Ali, MD) · nali2@fredhutch.org · 206-667-5854
    Contact: Principal Investigator (Naveed Ali, MD)
Study leads

  • Naveed Ali, MD

    Principal Investigator

    Fred Hutch/University of Washington Cancer Consortium

View source on ClinicalTrials.gov(opens in a new tab)